AIM
ULBI icon

Acrospire Investment Management’s Ultralife ULBI Stock Holding History

Acrospire Investment Management’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,963
Closed -$50K – 1351
2017
Q2 		$50K Buy
+6,963
New +$42.6K 0.05% 865
2016
Q2 		– Sell
-3,205
Closed -$16K – 2288
2016
Q1 		$16K Buy
+3,205
New +$17.4K 0.01% 1611

Other funds holding ULBI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GXMC
Global X Management Company New York $5.62B AUM 10.7% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Acrospire Investment Management's ULBI Position: Q3 2017 in Review

Acrospire Investment Management sold out of Ultralife (ULBI) in Q3 2017, closing a stake of 6,963 shares — an estimated $50K sold.

Acrospire Investment Management first reported a position in ULBI in Q1 2016 and held it in 2 quarters. The position peaked at $50K in Q2 2017. 38 funds tracked by Wall St. Rank hold ULBI as of Q3 2017.

  • Acrospire Investment Management reported no remaining Ultralife position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 6,963 Ultralife shares in Q3 2017, an estimated $50K.
  • Acrospire Investment Management first reported a position in Ultralife in Q1 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Ultralife position peaked at $50K in Q2 2017.
  • 38 funds tracked by Wall St. Rank held Ultralife as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.